Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

BACKGROUND: Biomarkers predictive of pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) of breast cancer are urgently needed. METHODS: Using a training/validation approach for detection of predictive biomarkers in HER2-negative breast cancer, pre-therapeutic core biopsies from f...

Descripción completa

Detalles Bibliográficos
Autores principales: Darb-Esfahani, S, Kronenwett, R, von Minckwitz, G, Denkert, C, Gehrmann, M, Rody, A, Budczies, J, Brase, J C, Mehta, M K, Bojar, H, Ataseven, B, Karn, T, Weiss, E, Zahm, D M, Khandan, F, Dietel, M, Loibl, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504944/
https://www.ncbi.nlm.nih.gov/pubmed/23079573
http://dx.doi.org/10.1038/bjc.2012.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504944/
https://www.ncbi.nlm.nih.gov/pubmed/23079573
http://dx.doi.org/10.1038/bjc.2012.475

Ejemplares similares